DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 103 filers reported holding DIPLOMAT PHARMACY INC in Q1 2015. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,000 | -60.0% | 180 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | -82.1% | 180 | -77.3% | 0.00% | – |
| Q2 2016 | $28,000 | -83.0% | 792 | -78.5% | 0.00% | -100.0% |
| Q2 2015 | $165,000 | +469.0% | 3,687 | +343.7% | 0.00% | – |
| Q1 2015 | $29,000 | -69.8% | 831 | -76.4% | 0.00% | – |
| Q4 2014 | $96,000 | – | 3,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Group I, LLC | 470,290 | $5,926,000 | 2.31% |
| Sandhill Capital Partners LLC | 422,605 | $5,325,000 | 1.46% |
| WEATHERBIE CAPITAL, LLC | 543,395 | $6,847,000 | 0.86% |
| Summit Creek Advisors LLC | 359,435 | $4,529,000 | 0.78% |
| RIVERBRIDGE PARTNERS LLC | 1,481,428 | $18,666,000 | 0.39% |
| Iguana Healthcare Management, LLC | 50,000 | $630,000 | 0.38% |
| HERMES INVESTMENT MANAGEMENT LTD | 1,513,081 | $19,065,000 | 0.33% |
| Cambridge Investment Research Advisors, Inc. | 1,376,956 | $17,350,000 | 0.32% |
| FCG ADVISORS, LLC | 34,000 | $428,000 | 0.19% |
| GW&K Investment Management, LLC | 737,025 | $9,287,000 | 0.18% |